20 sonuç
📅 2018 📈 SJR ≥ 2 📈 Atıflı
Excel'e Aktar
Scopus
🏆 Q1 · SJR 2,06 YÖKSİS Eşleşti
A comparative analysis of the engine performance, exhaust emissions and combustion behaviors of a compression ignition engine fuelled with biodiesel/diesel/1-butanol (C4 alcohol) and biodiesel/diesel/n-pentanol (C5 alcohol) fuel blends
· Cilt 165, s.1332-1351
Scopus
🏆 Q1 · SJR 2,074
Polyphenolic composition, enzyme inhibitory effects ex-vivo and in-vivo studies on two Brassicaceae of north-central Italy
· Cilt 107, s.129-138
Scopus
🏆 Q1 · SJR 2,182 YÖKSİS Eşleşti
What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
· Cilt 277, s.341-346
Scopus
🏆 Q1 · SJR 2,182 YÖKSİS Eşleşti
What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
· Cilt 277, s.341-346
Scopus
🏆 Q1 · SJR 2,043
Corporate carbon footprint for country Climate Change mitigation: A case study of a tannery in Turkey
· Cilt 635, s.60-69
Scopus
🏆 Q1 · SJR 2,012
Fabrication of lecithin-gum tragacanth muco-adhesive hybrid nano-carrier system for in-vivo performance of Amphotericin B
· Cilt 194, s.89-96
Scopus
🏆 Q1 · SJR 2,262 🔓 Açık Erişim YÖKSİS Eşleşti
Is the C-MAC videolaryngoscope plus Frova introducer suitable for intubating the trachea of every patient?
· Cilt 73, s.1033-1034
Scopus
🏆 Q1 · SJR 2,262 🔓 Açık Erişim YÖKSİS Eşleşti
Is the C-MAC videolaryngoscope plus Frova introducer suitable for intubating the trachea of every patient?
· Cilt 73, s.1033-1034
Scopus
🏆 Q1 · SJR 18,397 🔓 Açık Erişim YÖKSİS Eşleşti
Rivaroxaban for stroke prevention after embolic stroke of undetermined source
· Cilt 378, s.2191-2201
Scopus
🏆 Q1 · SJR 3,506 🔓 Açık Erişim YÖKSİS Eşleşti
Recombinant amelogenin regulates the bioactivity of mouse cementoblasts in vitro
· Cilt 10
Scopus
🏆 Q1 · SJR 2,115 🔓 Açık Erişim YÖKSİS Eşleşti
Relationship between race and outcome in Asian, Black, and Caucasian patients with spontaneous intracerebral hemorrhage: Data from the Virtual International Stroke Trials Archive and Efficacy of Nitric Oxide in Stroke trial
· Cilt 13, s.362-373
Scopus
🏆 Q1 · SJR 14,821 🔓 Açık Erişim YÖKSİS Eşleşti
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial
· Cilt 391, s.2107-2115
Scopus
🏆 Q1 · SJR 2,592 YÖKSİS Eşleşti
Static and dynamic mechanical responses of CaCO3 nanoparticle modified epoxy/carbon fiber nanocomposites
· Cilt 140, s.223-231
Scopus
🏆 Q1 · SJR 3,002 🔓 Açık Erişim YÖKSİS Eşleşti
Epidemiology of sepsis in intensive care units in Turkey: A multicenter, point-prevalence study
· Cilt 22
Scopus
🏆 Q1 · SJR 3,002 🔓 Açık Erişim YÖKSİS Eşleşti
Epidemiology of sepsis in intensive care units in Turkey: A multicenter, point-prevalence study
· Cilt 22
Scopus
🏆 Q1 · SJR 3,002 🔓 Açık Erişim YÖKSİS Eşleşti
Epidemiology of sepsis in intensive care units in Turkey: A multicenter, point-prevalence study
· Cilt 22
Scopus
🏆 Q1 · SJR 2,182 YÖKSİS Eşleşti
A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
· Cilt 270, s.42-48
Scopus
🏆 Q1 · SJR 2,092 YÖKSİS Eşleşti
In vitro and in silico perspectives on biological and phytochemical profile of three halophyte species—A source of innovative phytopharmaceuticals from nature
· Cilt 38, s.35-44
Scopus
🏆 Q1 · SJR 3,041
Pecan nuts: A review of reported bioactivities and health effects
· Cilt 71, s.246-257
Scopus
🏆 Q1 · SJR 2,259 YÖKSİS Eşleşti
Production of magnetically recoverable, thermally stable, bio-based catalyst: Remarkable turnover frequency and reusability in Suzuki coupling reaction
· Cilt 331, s.102-113